Print


ISIN and CFI Database for Non-Russian Financial Instruments that Meet the Requirements of Bank of Russia Regulation on Qualification

The Database contains ISIN and CFI codes allocated by authorized agencies in accordance with ISO 6166 and ISO 10962, and the CFI codes meet the requirements of paragraph 4.2 of the Directive of the Central Bank of the Russian Federation No. 4561-U dated October 3, 2017 "On the Procedure for the Qualification of Foreign Financial Instruments as Securities" (in the version of the Directive of Bank of Russia No. 4903-U dated 12.09.2018).

Information on non-Russian financial instruments is updated in real time as a result of processing clients' new requests relating to new instruments, and upon completion of NSD's daily monitoring of information on instruments already recorded in the Database.

Information on ISIN and CFI codes is provided by NSD to market participants solely for the purpose of qualification of non-Russian financial instruments as securities admitted for operations on the Russian market*.

 
Search key:
 
31221-31240 of 80021 results shown.
ISIN Issuer; Country Issue Description CFI Code Edition of IS0 10962 ISIN Status [?] Numbering Agency Information Source As of
US23283K1051 CYTORI THERAPEUTICS INC; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23283K2042 CYTORI THERAPEUTICS INC; US COM NEW ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23283K4022 CYTORI THERAPEUTICS INC; US COM PAR $0.001 ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23283M1018 CYTODYN INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23283PAG90 CYRUSONE LP / CYRUSONE FIN CORP; US SR NT DBFUGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23283R1005 CYRUSONE INC; US COM ESVXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23283X2062 CYTOSORBENTS CORP; US COM NEW ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23284C1027 CYXTERA TECHNOLOGIES INC; US CL A ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US23284F1057 CYTOMX THERAPEUTICS INC.; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23284M1009 CYTOCOM INC NEW; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-04-12
US23284P1030 CYTEIR THERAPEUTICS INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US23285D1090 CYTEK BIOSCIENCES INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US23291C1036 DMC GLOBAL INC; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23291QAA04 DME ARPT DESIGNATED ACTIVITY CO; IE LOAN PARTN NT 144A DBFSGR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2022-08-10
US23292B1044 D-MARKET ELECTR SVCS & TRADING; TR SPONSORED ADS REPSTG CL B EDSXDR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2023-01-10
US23292E1082 DIDI GLOBAL INC; KY SPONSORED ADS EDSXDR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2023-05-16
US2329461030 CYTYC CORP; US COM ESVUFR 2015 Deleted Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23302T1034 DAL INTL LTD; US COM ESVUFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US23304Y1001 DBS GROUP HLDGS LTD; SG SPONSORED ADR EDSXFR 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASBF 2021-11-26
US2330511013 DBX ETF TR; US X-TRACKERS MSCI EMERGING MKTS HEDGED EQUITY FD CEMJLS 2015 Updated Standard & Poor's - CUSIP Service Bureau, USA, UNITED STATES ASB 2021-09-30

* NSD does not make any representation or warranty as to the completeness or reliability of the information contained herein, nor does it make any warranty regarding its consistency with the purposes for which the information is used, including but not limited to, commercial purposes. The information published on this website is not to be construed as an offer to effect any deal with financial instruments, and should not be used for commercial or other purposes; nor does it represent an offer from NSD to render any services; nor does it make any warranty or representation of reliability of certain financial instruments or persons (including but not limited to, issuers, securities market participants, etc.).


For further information, please refer to NSD’s experts.

Printed version

Print